- Home
- THFF vs LAB Comparison
THFF vs LAB Comparison
Compare THFF & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- LAB
- Stock Information
- Founded
- THFF 1984
- LAB 1999
- Country
- THFF United States
- LAB United States
- Employees
- THFF N/A
- LAB N/A
- Industry
- THFF Major Banks
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- THFF Finance
- LAB Industrials
- Exchange
- THFF Nasdaq
- LAB Nasdaq
- Market Cap
- THFF 578.4M
- LAB 562.1M
- IPO Year
- THFF N/A
- LAB 2011
- Fundamental
- Price
- THFF $48.64
- LAB $1.09
- Analyst Decision
- THFF Buy
- LAB Strong Buy
- Analyst Count
- THFF 2
- LAB 3
- Target Price
- THFF $56.50
- LAB $2.88
- AVG Volume (30 Days)
- THFF 98.3K
- LAB 1.5M
- Earning Date
- THFF 04-29-2025
- LAB 05-07-2025
- Dividend Yield
- THFF 4.24%
- LAB N/A
- EPS Growth
- THFF N/A
- LAB N/A
- EPS
- THFF 4.00
- LAB N/A
- Revenue
- THFF $201,592,000.00
- LAB $174,432,000.00
- Revenue This Year
- THFF $26.41
- LAB N/A
- Revenue Next Year
- THFF $2.60
- LAB $12.77
- P/E Ratio
- THFF $12.24
- LAB N/A
- Revenue Growth
- THFF N/A
- LAB 64.03
- 52 Week Low
- THFF $34.58
- LAB $0.99
- 52 Week High
- THFF $53.60
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- THFF 42.45
- LAB 40.52
- Support Level
- THFF $49.69
- LAB $1.05
- Resistance Level
- THFF $50.79
- LAB $1.21
- Average True Range (ATR)
- THFF 1.19
- LAB 0.07
- MACD
- THFF -0.12
- LAB 0.01
- Stochastic Oscillator
- THFF 27.22
- LAB 19.05
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.